Literature DB >> 3977967

Further studies of human whole-body radiofrequency absorption rates.

D A Hill.   

Abstract

Further studies of human whole-body radiofrequency (RF) absorption rates were carried out using a TEM-cell exposure system. Experiments were done at one frequency near the grounded resonance frequency (approximately 40 MHz), and at several below-resonance frequencies. Absorption rates are small for the K and H orientations of the body, even when grounded. For the body trunk in an E orientation, the absorption rate of a sitting person is about half of the rate for the same person standing with arms at the sides; the latter in turn is about half the rate for the same subject standing with arms over the head. Two-body interactions cause no increase in absorption rates for grounded people. They do, however, increase the absorption rates for subjects in an E orientation in free space; the largest interaction occurs when one subject is lambda/2 behind the other (as seen by the incident wave). When these results are applied to practical occupational exposure situations, the whole-body specific absorption rate does not exceed the ANSI limit of 0.4 W/kg for exposures permitted by the ANSI standard (C95.1-1982) at frequencies from 7 to 40 MHz.

Entities:  

Mesh:

Year:  1985        PMID: 3977967     DOI: 10.1002/bem.2250060104

Source DB:  PubMed          Journal:  Bioelectromagnetics        ISSN: 0197-8462            Impact factor:   2.010


  2 in total

1.  In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.

Authors:  Jen-Jie Chieh; Kai-Wen Huang; Yang-De Lee; Herng-Er Horng; Hong-Chang Yang; Chin-Yih Hong
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

2.  Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo.

Authors:  Kai-Wen Huang; Jen-Jie Chieh; In-Tsang Lin; Herng-Er Horng; Hong-Chang Yang; Chin-Yih Hong
Journal:  Nanoscale Res Lett       Date:  2013-10-08       Impact factor: 4.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.